Table 2.
Immunohistochemistry results.
| Case | ALK | Vimentin | Dsemin | SMA | S-100 | LCA | CD34 | Ki-67 | CK | CD68 | CD117 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | / | / | / | / | / | / | / | / | / | / | / |
| 2 | – | / | – | / | – | / | – | – | / | / | / |
| 3 | + | + | – | / | / | / | – | <20% + | – | / | / |
| 4 | + | + | – | / | / | / | + | 1% + | ± | + | ± |
| 5 | + | + | ± | / | / | / | – | 10% + | – | – | / |
| 6 | / | / | / | / | / | / | / | / | / | / | / |
| 7 | + | + | ± | / | / | / | - | 5% + | + | + | – |
| 8 | + | + | ± | / | / | ± | – | 15% + | – | + | – |
| 9 | + | + | ± | / | – | – | – | 10% + | ± | ± | – |
| 10 | + | + | – | / | – | – | – | 15% + | ± | + | – |
| 11 | – | + | ± | / | – | / | – | 10% + | – | + | – |
| 12 | + | + | + | / | – | / | – | 25% + | ± | + | – |
| 13 | – | + | + | / | - | / | - | ± | / | / | / |
| 14 | + | + | – | + | – | / | – | 20–70% + | – | + | / |
| 15 | + | + | ± | + | – | + | – | 30% + | ± | + | / |
| 16 | – | + | ± | + | – | – | – | 75% + | / | – | / |
| 17 | – | + | – | / | – | – | – | ± | / | – | – |
| 18 | + | + | + | + | – | – | – | 10% + | + | – | – |
| 19 | – | + | + | – | ± | – | – | 10% + | + | / | / |